Perampane oF. Controlled substance- awaiting DEA of. classification 00 Adverse effects Dizziness Gait disturbance/falls o000oc0= Somnolence Weight gain Psychiatric and behavioral effects (aggression hostility irritability anger, homicidal ideation)can occur with or without psychiatric history(2-20%) KENTUCKY College of PharmacyPerampanel • Controlled substance – awaiting DEA classification • Adverse effects – Dizziness – Gait disturbance/falls – Somnolence – Weight gain – Psychiatric and behavioral effects (aggression, hostility, irritability, anger, homicidal ideation) can occur with or without psychiatric history (2-20%)